http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010088258-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05d4136896541ec7969a7bff9f3092bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27779169c6d73bdc6cc08b9f87654e46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f1e9f0d3d21b54d01ba8cbc32d13104
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0019
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2010-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ff16d3a2a5dd09a7b1d36aa23966c1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b774a2a6401614982ba4e1141c805226
publicationDate 2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010088258-A2
titleOfInvention Ocular implant with stiffness qualities, methods of implantation and system
abstract Described herein are devices and methods for treating eye conditions. Described is an ocular implant (105) including an elongate member having an internal lumen forming a flow pathway, at least one inflow port communicating with the flow pathway, and at least one outflow port communicating with the flow pathway. The elongate member is adapted to be positioned in the eye such that at least one inflow port communicates with the anterior chamber (ac), at least one outflow port communicates with the suprachoroidal space (schs) to provide a fluid pathway between the anterior chamber and the suprachoroidal space when the elongate member is implanted in the eye. The elongate member has a wall material imparting a stiffness to the elongate member. The stiffness is selected such that after implantation the elongate member deforms eye tissue surrounding the suprachoroidal space forming a tented volume.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016156727-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110913809-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786402-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110913809-B
priorityDate 2009-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009182421-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007191863-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394320
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107689
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID889463
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID889463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409982724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7489

Total number of triples: 28.